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Abstract: Chitosan macro- and micro/nano-gels have gained increasing attention in recent years,
especially in the biomedical field, given the well-documented low toxicity, degradability, and non-
immunogenicity of this unique biopolymer. In this review we aim at recapitulating the recent gelling
concepts for developing chitosan-based physical gels. Specifically, we describe how nowadays
it is relatively simple to prepare networks endowed with different sizes and shapes simply by
exploiting physical interactions, namely (i) hydrophobic effects and hydrogen bonds—mostly
governed by chitosan chemical composition—and (ii) electrostatic interactions, mainly ensured
by physical/chemical chitosan features, such as the degree of acetylation and molecular weight,
and external parameters, such as pH and ionic strength. Particular emphasis is dedicated to potential
applications of this set of materials, especially in tissue engineering and drug delivery sectors. Lastly,
we report on chitosan derivatives and their ability to form gels. Additionally, we discuss the recent
findings on a lactose-modified chitosan named Chitlac, which has proved to form attractive gels both
at the macro- and at the nano-scale.
Keywords: chitosan; gel; physical interactions; gelling mechanisms; tissue engineering; drug delivery;
chitosan-derivatives; Chitlac
1. Introduction
The term “gel” is usually associated with highly hydrated networks in which two components
are present in different proportion, i.e., the solvent—the one prevailing in mass—and the polymeric
solute; typically, the latter ones are either natural or synthetic macromolecules able to properly retain
a large amount of the former component. Although this simple description is reasonably valid, it is
complicated to define gels in detail. One of the safest ways to categorize pure viscous liquids from
strong elastic gels is to assess their mechanical behavior, specifically undergoing the system to strain
under oscillatory conditions for a large range of frequencies using rheometry as the analytical tool [1].
For limiting angular frequency, ω, namely ω → 0 , viscous liquids will display the storage modulus,
G’, lower than the loss modulus, G”; they typically scale with the following laws: G′ ≈ ω2 and
G′′ ≈ ω. Conversely, strong gels will show G′ >> G” with almost constant values over a large interval
of frequencies, thus behaving as elastic solids.
The use of gels is widespread and growing, especially in the biomedical sector [2–4]. For instance,
tissue engineering and regenerative medicine approaches require suitable matrices, described as
“scaffolds”, which should recapitulate the physical milieu of the extracellular microenvironment.
Hence, the fabrication of macro-gel networks endowed with peculiar composition and mechanical
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behavior would be beneficial for cellular anchoring, colonization and metabolic activity. Moreover,
the application of micro- and nano-gels is attractive especially for drug delivery purposes.
Obviously, this type of material should be biocompatible and, in general, biodegradable in due
time, without eliciting any immune response if implanted or administered. Naturally-derived
polymers, such as polysaccharides, are nowadays exploited for the fabrication of artificial extracellular
matrix (ECM)-like macro-networks and micro- and nano-systems, since they possess most of the
above-mentioned properties. In this respect, chitosan represents a very attractive biopolymer both for
tissue engineering and drug delivery purposes [5,6].
The present review article summarizes the basilar gelling concepts for developing chitosan and
chitosan-derivatives gels. Although the fabrication of chitosan-based gels may be achieved through
different strategies, herein we focus the attention exclusively on those materials synthesized by
exploiting physical interactions. The potential applications of such chitosan gels in the biomedical
field are discussed as well. In the last section, we report on a lactose-modified chitosan produced by
our research group, named Chitlac, or CTL, which recently proved to form both macro- and nano-gels,
with very interesting physical and biological features.
2. An Overview of Chitosan Physical/Chemical Properties and Biological Activities
Chitosans (CH) are considered as a family of binary heteropolysaccharides composed of β-1→ 4
linked 2-acetamido-2-deoxy-β-D-glucopyranose (GlcNAc, the “acetylated”, i.e., the A unit) and
2-amino-2-deoxy-β-D-glucopyranose (GlcNH2, the “deacetylated”, i.e., the D unit) residues, present in
different relative proportion and sequence along the chain (Figure 1). Generally, D sugars are higher
in number with respect to the A ones. Chitosans typically show an acetylation degree in the range
0–70%. As a general consideration, both building units are randomly distributed along the polymer
chain, with a quasi-ideal Bernoullian arrangement of A and D sugars.
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Figure 1. Schematic structure of chitosan: glucosamine (D) and N-acetyl-glucosamine (A) units. 
Chitosan derives mainly from chitin—the second most abundant polysaccharide on Earth—
present in the outer skeleton of Arthropoda, or from the cell walls of certain fungi [7]. When chitin is 
used as the raw material, both homogeneous and heterogeneous deacetylation processes using 
alkaline conditions allow forming chitosans with a different fraction of A units (FA), [8] at the same 
time limiting chain depolymerization. Deacetylation processes under alkaline conditions are, in fact, 
well tolerated with respect to acidic ones, the latter leading to a severe cleavage of glycosidic linkages. 
Oppositely, homogeneous re-N-acetylation processes of highly deacetylated chitosans using 
hydroalcoholic media allow modulating the polymer chemical composition, producing chitosans 
with different FA [9–11]. 
Concerning solution properties, chitosans behave as amphiphilic polymers because of the more 
hydrophobic nature of A sugars and the more hydrophilic character of D units. As a general 
consideration, all chitosans are water-soluble in acidic conditions due to the protonation of amino 
groups at the C2 position: in these conditions, chitosans behave as polyelectrolytes with a linear 
charge density which depends mainly on both FA and pH. The pKa was found to span from around 
6.3 to 7.2  (𝛼 = 0.5), depending on the FA of chitosan [9], albeit other works reported no significant 
dependence of pKa on FA [12,13]. 
Figure 1. Schematic structure of chitosan: glucosamine (D) and N-acetyl-glucosamine (A) units.
hitosan derives mainly from chitin—the second most abundant polysaccharide on Earth—present
in the outer skeleton of Arthropoda, or from the cell walls of certain fungi [7]. When chitin is used
as the raw material, both homogeneous and heterogeneous deacetylation processes using alkaline
conditions allow forming chitosans with a different fraction of A units (FA), [8] at the same time limiting
chain depolymerization. Deacetylation processes under alkaline conditions are, in fact, well tolerated
ith respect to acidic ones, the latter leading to a severe cleavage of glycosidic linkages. Oppositely,
homogeneous re-N-acetylation processes of highly deacetylated chitosans using hydroalcoholic media
allow modulating the polymer chemical composition, producing chitosans with different FA [9–11].
Concerning solution properties, chitosans behave as amphiphilic polymers because of the more
hydrophobic nature of A sugars and the more hydrophilic character of D units. As a general
consideration, all chitosans are water-soluble in acidic conditions due to the protonation of amino
groups at the C2 position: in these conditions, chitosans behave as polyelectrolytes with a linear charge
density which depends mainly on both FA and pH. The pKa was found to span from around 6.3 to 7.2
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(α = 0.5), depending on the FA of chitosan [9], albeit other works reported no significant dependence
of pKa on FA [12,13].
The solubility of chitosans at neutral pH and above is somewhat limited when typical commercial
chitosans are considered. As an example, a medium molecular weight chitosan with FA < 0.3 would
precipitate when pH is increased toward neutrality. Two characteristics mainly contribute to chitosan
solubility at neutral and slight alkaline pH: the molecular weight and the value of FA. A highly
deacetylated chitosan with FA ~0 begins to be soluble at neutral pH if the molecular weight is reduced
to the point of reaching a degree of polymerization, DP < 10 [14]. On the other hand, medium/high
molecular weight chitosans are soluble at neutral pH only if the acetylation degree is approximately
40% and above, typically in the range 0.4 < FA < 0.6 [15,16].
From the biological point of view, chitosans are considered as low-toxic, non-immunogenic,
and biodegradable polysaccharides. In the latest years, chitosans were extensively studied in terms of
antibacterial properties and bioactivity. Different papers report on antibacterial properties. Zheng et al.
demonstrated that the antimicrobial activity of chitosans can be modulated by varying polymer
molecular weight and concentration [17]. A recent study by Younes et al. reported that the antibacterial
activity of chitosan against Gram-negative bacteria increases with decreasing FA, molecular weight and
pH [18]. When Gram-positive bacteria are considered, FA and pH seemed to have a minor influence.
The overall results seem to suggest that electrostatic interactions between the negative bacterial cell
wall and positively-charged -NH3+ groups are involved in its antibacterial behavior, albeit hydrophobic
and chelating effects cannot be excluded [19]. With respect to its antifungal activity, the influence of
molecular weight and FA of chitosan was correlated to the particular type of fungus considered [18].
Chitosans were also studied in terms of anti-HIV-1, antitumor and antioxidant activities, as documented
in a recent review article [20]. Given all aforementioned properties, chitosans find application in
very different sectors, spanning from biomedical—e.g., for the production of biomaterials for tissue
engineering and drug delivery purposes—to water treatment and the food industry.
3. Physical Gelation of Chitosan
Unlike other marine polysaccharides such as alginates and carrageenans, chitin—and its
N-deacetylated derivative, chitosan—are not present in the gel form in nature, where it plays
mostly a structural role forming very strong fibrillar structures. Different research groups have
proposed in recent years challenging strategies to promote the sol-gel transition of N-deacetylated
chitins (chitosans). It is widely accepted that two ways can be essentially undertaken to form
chitosan gels, i.e., by means of “physical” or “chemical” reticulation processes. In the latter case,
covalent bonds among chains are exploited to form permanent networks. Small molecules, as well as
glutaraldehyde, diglycidyl ether, diisocyanate or diacrylate are typically used to prepare chemical gels
of chitosan. However, the well-known toxicity of most of such molecules represents a serious concern.
Alternative strategies were proposed to limit this flaw, while promoting polymer-polymer reticulation.
The authors of the present review refer elsewhere for a thorough description of the common concepts
for synthesizing chitosan gels through chemical processes [6,21,22].
Physical chitosan gels are perhaps the most appealing systems, due to, in general, lower toxicity,
the possibility of tuning both extent and rate of gel swelling, degradation and mechanical behavior.
As a general consideration, however, physical chitosan gels are characterized by lower mechanical
properties with respect to chemical gels. The sol/gel transition in physical gels is potentially achievable
by varying physical/chemical parameters, such as temperature, pH, and ionic strength, or by the
addition of suitable counterions. Electrostatic and hydrophobic interactions together with hydrogen
bonds cooperate for the formation of entangled networks. As to ionic interactions, pH and ionic
strength play a key role in gel formation. Chitosans behave as polyelectrolytes depending on the pH
value of the solution. It means that chitosans can interact with ions, small molecules or macromolecules
bearing opposite charges in a typical pH range of 4–6. The kinetics of self-assembling is generally
very fast, albeit it can be easily tuned by increasing the ionic strength or crosslinker concentration [23].
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Although the formation of chitosan gels in the micro/nano-size range is now relative easy to achieve
via coacervation methodologies, more demanding processes are required for fostering the controlled
gelation of chitosan at the macro-scale. As to the role of hydrophobic interactions and hydrogen
bonding, additional variables affect the gelation of chitosan, such as polymer chemical composition
(namely, the degree of acetylation, as a parameter tuning both types of interaction) and the use
of co-solvents.
4. Chitosan Gels without External Crosslinkers
One of the simplest ways to produce physical gels of chitosan—without the use of any external
gelling agent—is to precisely modulate the polymer chemical composition. Hirano et al. reported the
formation of a true physical chitosan gel via controlled re-N-acylation processes of an almost completely
deacetylated chitosan [24]. Specifically, chitosan solutions were treated with large amounts of acetic
anhydride as acetyl group donor. Authors claimed that the excess of acetic anhydride was pivotal for
the gel formation, leading to an acetylation of both amino and hydroxyl groups present in chitosan.
The final result was a colorless, transparent, and rigid gel composed of highly acetylated polymer
chains, showing a degree of substitution of 2.36 per monosaccharide unit. Molecular aggregation
between acetylated polysaccharide chains was proposed as gelation mechanism.
Some years later, Moore and Roberts gave insights into such gelling system investigating reaction
variables such as the concentration of chitosan, that of anhydride, and the effect of temperature [25].
They concluded that an increase of temperature, anhydride and polymer concentrations speeded up
the gelation process. Furthermore, they observed syneresis (about 50% of water loss) in the first 21 h
after gelation. In a concomitant document the same authors attempted at elucidating the mechanism of
gelation: this seemed to take place through the formation of crosslinks, likely ensured by hydrophobic
interactions between A residues, leading to the formation of micellar junction points [26]. Moore and
Roberts observed that gelation occurred upon reaching approximately 70% of formation of type A
sugars, thus switching the nature of chitosan from a polyelectrolyte to a hydrophobic polysaccharide
characterized by very low solubility in aqueous solutions. The final result was a collapse of the highly
extended polymer to more compact entangled chains.
The same gelling system was further studied by Domard and co-workers [27]. They confirmed
most of the evidences reported by Moore and Roberts, identifying some critical parameters allowing
for gel formation. For instance, a minimum molar ratio R between the anhydride over D sugars
of 1.3—yielding chitosans with FA around 0.8—was found necessary for the complete gelation.
Moreover, it seemed that a threshold degree of polymerization was necessary for the formation
of macroscopic gels, since 30 > DPw > 280 allowed only the formation of micro-gels. Beyond a degree
of polymerization of 280, macroscopic networks formed. The influence of the nature of co-solvents
(alcohols) was also investigated. In fact, the presence of co-solvents such as methanol was found
to be fundamental in order to prevent O-acetylation, [28] and to generally decrease the dielectric
constant of the media, thus fostering the N-acetylation process. Domard et al. demonstrated that
both ethanol and 1,2-propanediol were suitable for gel formation, albeit showing different kinetics.
Indeed, the gelation process was more rapid using the former co-solvent, likely due to its low viscosity
with respect to the latter alcohol. Apart from kinetics aspects, it seemed that the two solvents showed
no difference upon gelation, suggesting that the alcohol was necessary solely to avoid any side
reaction [27]. The resulting gels were studied in a further contribution in terms of syneresis and
swelling, pointing at the pivotal role played by the final acetylation degree, since weak syneresis and
swelling phenomena were observed up to FA = 0.88. Above this value, the weight loss increased with
FA [29]. Swelling experiments demonstrated that the solvent exchange between gels and surrounding
environment was not fully reversible due to the formation of new junctions during the de-swelling
step. Overall, given the (weak) polyelectrolyte character of highly acetylated chitosans used in this
study, the syneresis was found to depend on pH and the ionic strength of the media.
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The same authors proposed the application of such gelling system as injectable material for
periodontal surgery purposes [30]. More in detail, they fine-tuned the optimal conditions of injection
by varying different parameters, such as the molar ratio R, the temperature, and the concentration
of chitosan. The optimum experimental conditions limited the syneresis, improved the mechanical
properties of the gel, and determined a viscosity suitable for the injection.
Physical chitosan gels were also formed without the use of any external crosslinker in the presence
of an aqueous ammonia solution as described in [31] (Figure 2).
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In order to allow for gelation, three key conditions had to be met: (i) the initial concentration of
solutions had to be over the critical concentration of chain entanglements, C*; (ii) the hydrophobic/
hydrophilic balance had to achieve a critical value; and (iii) an interphase, corresponding to a
bidimensional sol-gel transition, had to be created uniformly. The latter condition was achieved
by the use of gaseous alkaline ammonia instead of an alkaline solution, since a heterogeneous gelation
was noticed when chitosan was dialyzed against an aqueous ammonia solution. In these experimental
conditions, the NH3 progressively neutralized the (weaker) primary amine functions of chitosan
starting from the surface of solution to the bottom of the reactor, thereby promoting a decrease of the
apparent charge density of chitosan chains. Upon exceeding a critical value, the transition sol-gel was
demonstrated, wherein hydrophobic interactions and hydrogen bonds both cooperate to the formation
of the network. The authors claimed that gelation kinetics could be speeded up upon increasing the
FA of chitosan samples (meaning that type A sugars are pivotal for the setting up of hydrophobic
interactions) and the polymer concentration. The key role played by the hydrophobic interactions in
the formation of macroscopic gels was also proved by assessing the mechanical properties of this set of
materials. Specifically, the authors found that the equilibrium storage modulus, Ge, which corresponds
to the value of elastic modulus at the plateau for low frequencies, increased upon increasing FA,
stemming from a higher number of junctions per unit volume. Furthermore, it was found that the
influence of the polymer concentration, Cp, on Ge was more important than that of FA, since Ge
scaled with Cp according to the following power law: Ge ∝ C2.3, suggesting that the presence of more
entangled polymer chains positively affected the formation of a higher amount of junctions per unit
volume than the number of type A sugars in the sample. Overall, the authors identified the optimum
experimental conditions for gel synthesis, which resulted to have an FA value around 0.40, and a final
polymer concentration close to 1.5% w/w.
Recently Fiamingo et al. exploited gaseous ammonia for gelling chitosan solutions at different
polymer concentration. Resulting gels were used in vivo to evaluate the potential regeneration of
infarcted myocardium, showing that such materials were well incorporated onto the epicardial surface
of the heart, with a general lack of toxicity [32]. In parallel, physical chitosan gels were synthesized
and subsequently fragmented, in order to obtain an injectable suspension of micro-gels in a range of
dimensions around 20 µm [33]. This type of material was devised for spinal cord injury restoration
and axon regeneration. Experimental data using a spinal cord injury model in rats demonstrated that
the implantation of such micro-gels allowed the repair, to some extent, of spinal tissue without being
combined with additional drugs.
The formation of chitosan macro-gels was also investigated by the same research group
using hydroalcoholic media [34,35]. Chitosans at different FA were solubilized using acetic acid
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or hydrochloric acid as solvent and alcohols were added in equal amount. The resulting mixtures were
continuously stirred and water was allowed to evaporate up to the formation of tridimensional
networks. In this approach the hydrophilic/hydrophobic balance is shifted toward the latter,
thus promoting the formation of hydrophobic interactions and hydrogen bonds among chains.
The authors demonstrated that water completely evaporated within approximately 1000 min, and the
resulting mixtures were composed only by chitosan, alcohol, and residual amounts of acids used for the
polymer solubilization. One key aspect to consider concerns the choice of the alcohol, whose boiling
point must be higher with respect to water. The role of alcohol was to reduce the dielectric constant
of the medium and possibly to participate in the formation of hydrophobic interactions between
chitosan chains. At the end of the process, resulting gels were neutralized using sodium hydroxide
and then washed extensively in order to eliminate any trace of alcohol. Hence, the final material was
composed only by chitosan and water. Critical experimental variables for such gelation mechanism
were: (i) the apparent charge density of chitosan; (ii) the dielectric constant of the solvent; (iii) FA;
(iv) the temperature. The kinetics of gelation was also investigated by rheometry, [36] pointing at a key
role of FA and polymer concentration in shortening the gelation time; furthermore, highly acetylated
chitosans showed higher mechanical properties.
The gelation of chitosan using hydroalcoholic media has been exploited for the fabrication of
bio-inspired bilayer physical gels for the treatment of full-thickness burn injuries, showing that such
chitosan-based materials were well tolerated in vivo, promoting tissue regeneration [37]. A controlled
interruption of gelation has been achieved by simple imbibition of non-neutralized alcohol gels
in sodium hydroxide, [38] thus generating an onion-like multi-membrane. It was found that the
number of membranes composing the final gel could be easily tuned by varying the neutralization
steps. Such multi-membrane materials showed pores in a range of tens of nanometers, which do
not allow cell infiltration [39]. Anyway, this kind of materials proved to support the aggregation
of chondrocytes without losing their phenotype when cells were loaded directly within the gels.
Chitosan hydroalcoholic solutions also allowed for the formation of macroscopic gels when neutralized
using NaOH or NH4OH [40]. Indeed, Rami et al. demonstrated the formation of physical chitosan gels
characterized by different stiffness (Young’s modulus in the range 1–31 kPa, depending on FA). This set
of materials behaved as suitable substrates for cellular anchoring, albeit no infiltration throughout
the gels was noticed in vitro. It was found that the cell morphology and spreading depended on
the gel stiffness: specifically, highly deacetylated chitosans allowed for the formation of stiffer gels,
which proved to better foster cell spreading.
5. Ionic Chitosan Macro-Gels
When a polycation such as chitosan is fully charged, meaning that it is well below its
pKa, and multivalent anions or negatively-charged macromolecules are added to the solution,
two phenomena are essentially expected to occur: (i) if the concentration of chitosan, CP, is below or
close to that of chain entanglement, C* (calculated as the inverse of the intrinsic viscosity 1
[η]
) [34,41]
an ordered liquid-liquid phase separation—simple or complex coacervation based on the number of
macromolecules involved in the process—will manifest only in the case of very precise values of the
[crosslinker]/[chitosan]r.u. molar ratio; (ii) on the contrary, for CP > C*, the system will evolve into
irregular macro-aggregates that will precipitate. If the concentration of chitosan is quite larger than C*,
whatever the crosslinker amount, inhomogeneous gelation and, often, precipitation phenomena will
occur. Such phenomena are mostly governed by the very fast self-assembling of the polyeletrolyte
when exposed to anionic crosslinkers. Hence, proper methodologies are required to form homogeneous
ionic chitosan macrogels.
Sacco et al. reported the fabrication of cylindrical chitosan gels through a controlled external
gelation using tripolyphosphate (TPP) as crosslinker. TPP is a multivalent anion, which shows from
one to five negative charges depending on pH. A typical gelation requires that chitosan is acid
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solubilized in order to protonate all D sugars. The resulting chitosan solution was casted into a mold,
and subsequently placed in a gelling bath containing TPP (Figure 3) [42].Gels 2018, 4, x FOR PEER REVIEW  7 of 28 
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Figure 3. Experi ental setup for developing chitosan-tripolyphosphate (TPP) acroscopic gels via
external gelation. dapted ith per ission fro [42], Copyright 2014 A erican Chemical Society.
This approach avoids the instantaneous gelation of chitosan and allows for a uniform distribution
of the crosslinker throughout the solution. The effect of experimental variables, such as polymer
and TPP concentration and of the presence of the supporting monovalent salt NaCl were explored
to find the suitable conditions to form homogeneous cylindrical gels. The mechanical properties
were found to vary simply by changing the concentration of chitosan or that of the crosslinker.
The multivalent anion pyrophosphate (PPi) was also investigated for the fabrication of such gels [43].
For both the crosslinker types, i.e., TPP and PPi, it was hypothesized that the macroscopic gelation
occurred through three consecutive steps, the first two common with what is known for micro-gel
formation [23]: (i) the formation of small primary complexes; (ii) the subsequent aggregation into
larger micro-gels of higher-order; and (iii) the aggregation of micro-gels via both electrostatic and van
der Waals interactions among chains. Contrary to the chitosan-TPP gelling system, it was found that
PPi allowed for the formation of inhomogeneous gels characterized by lower mechanical properties.
Very recently it was demonstrated that the formation and mechanical properties of this set of materials
could be strongly affected by intrinsic polymer features, such as its molecular weight, and its chemical
composition, as FA [10]. Specifically, it was found that the complete wall-to-wall gelation of chitosan
required a minimum average of 152 sugars per chain; the gel stiffness increased with increasing
molecular weight while the elasticity was almost independent of molecular weight. By varying the
FA, it was possible to switch from very stiff and brittle gels to weaker but much more elastic ones.
This kind of materials were studied for biomedical purposes as such, or freeze-dried in order to obtain
soft and pliable membranes [42,44,45]. In the first case, chitosan gels did not show any cytotoxicity
when put in contact with mammalian cells. The ability to host cells was verified by means of confocal
microscopy, pointing at the pivotal role played by such matrices in cellular anchoring. Furthermore,
chitosan gels were found to behave as suitable depots of macromolecules, since the release kinetics can
be modulated by changing the crosslinker type or the molecular weight of payload [45]. Chitosan gels
were freeze-dried to obtain pliable membranes as such, or implemented with silver nanoparticles.
The latter material showed very interesting antibacterial properties without being cytotoxic toward
mammalian cells, thus being a suitable candidate for the treatment of non-healing wounds [44].
A rapid ionic gelation of chitosan using a 6-phosphogluconic trisodium salt (6-PG-Na+) was
recently reported [46]. The formation of a macroscopic gel was demonstrated by rheometry. From the
biological point of view, such gels did not cause toxicity and dermal irritation, with potential
application as vehicle for topical administration or as wound dressing.
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Vårum and co-workers reported on the fabrication of macroscopic ionic chitosan gels using
mannuronan oligomers as crosslinkers (Figure 4) [14].
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This gelling system is based on two main steps: th first one requires that a medium acetylated
chitosan (FA = 0.40) is mixed with mannuronan oligomers at a pH around 7.5. Chitosans ith FA ≥ 0.40
are well known to be soluble at approximately neutral pH and above, [15] showing a m ll charge
density. This allows such chitosans to be mixed with polyanions without phase separation. The second
step requires the addition of a proton donor such as glucono-δ-lactone (GDL) in order to slowly
decrease the pH of the mixture. It follows that chitosan progressively gains positive charges due to
the protonation of amino groups at C2 position. Hence, electrostatic interactions with mannuronan
oligomers take place in a range of pH 4–6. The final material is an ionic gel with peculiar mechanical
properties. In the same contribution, the authors demonstrated that the present gelling concept worked
also inverting the electrical nature of the components, inasmuch an alginate (anion) gel was obtained
using chitosan (cation) oligomers (Figure 4).
Ionic chitosan gels could be obtained also using metallic anion based on Mo(VI) [47]. In the
case reported by Draget et al. a dispersion of MoO3 is added to a chitosan solution and the sol-gel
transition was verified by rheometry. The gelation mechanism is based on the gradual ionic interaction
under acidic conditions between molybdate polyoxyanion (Mo7O246−) and D residues on chitosan.
Resulting gels showed lower mechanical properties if compared with Ca2+-alginate gels produced via
internal gelation using similar experimental conditions, due to the different binding mode of Mo7O246−
to chitosan with respect to Ca2+ in alginate. Finally, the authors demonstrated that Mo containing
chitosan gels swelled/deswelled depending on the ionic strength of the incubation medium.
6. Ionic Chitosan Micro- and Nano-Gels
Chitosan forms polyel c olyte complexes with negatively charged smal molecules or
macromol cules if the concentrati n of polymer is below or close to C*. Differe t polyanions have
been extensively investigated to form mic - d nano-gels with chitosan, inc uding inorganic ions
such as TPP, polysaccharides as hyalur nan or lginate and synthetic polymers [48,49]. The i notropic
micro- or nano-gelation of chitosan usually requires a single injection or a dropwise titration of the
polyanion into the chitosan solution at room temperature until a turbid system is obtained [50,51],
thus indicating the onset of coacervation. The final outcome is a phase separation where a more
viscous polymer rich phase—the “coacervate”—is noticed [52]. There are two ways to define
coacervation phenomena. The “simple” coacervation refers to those systems composed by only one
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macromolecule, while “complex” coacervation deals with systems containing at least two—oppositely-
charged—polyelectrolytes.
6.1. Simple Coacervation
The first evidence of the possibility to form nano-gels based on chitosan was reported by Calvo
and co-workers in 1997 [50], with the use of TPP as the crosslinker. The authors evaluated the
influence of chitosan and TPP concentrations on the physical-chemical properties of resulting nano-gels.
Three different results were observed: (i) solutions at high chitosan concentration and low TPP amounts;
(ii) insoluble aggregates at low chitosan concentration; and (iii) nano-gels at intermediate chitosan and
TPP concentrations.
Lapitsky and co-workers extensively investigated the formation mechanism of chitosan/TPP
micro-gels and their properties by tuning different parameters such as FA and molecular weight of
chitosan, pH, ionic strength and concentrations of polymer and crosslinker [23,53–56]. The kinetics
of gelation was dramatically slowed down simply tuning the TPP and monovalent salt (NaCl)
amounts [23]. Micro- and nano-gel formation rates resulted to be extremely sensitive to NaCl and
TPP concentrations, and the formation process occurred in two stages as already discussed (Figure 5).
The same authors also proved that large amounts of NaCl (e.g., 150 mM) enhanced the colloidal stability
of chitosan/TPP micro-gels during their formation. In those experimental conditions, chitosan-TPP
binding was weakened, so the bridging of the newly-formed micro-gels was inhibited, leading to
narrow size distributions. Conversely, at high ionic strengths (e.g., 500 mM) the chitosan-TPP binding
was weakened to the point that micro-gels did not form anymore. The suitability for biomedical
applications of the chitosan/TPP micro-gel system is strictly influenced by its stability to aggregation
and dissolution. Huang et al. investigated the effects of chitosan FA and particle concentration at
physiological pH and ionic strength [55,56]; the aggregation rate increased with increasing pH and
decreased with increasing FA.
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The final micro-gel is formed by a controlled aggregation of primary nanoparticles into larger
coacervates. Adapted with permission from [23], Copyright 2012 American Chemical Society.
Chitosan-based nano-gels usually tend to aggregate after lyophiliz tion and spra -drying [57].
Rampino et al. investigated the possibility to improve nanoparticle stability after drying in the presence
of cryoprotect nts such as trehalose, PEG and mannitol [58]. Trehalose was the best performing agent,
and resulting f rmulations resulted biocompatible according to in vivo tests using chick embryos.
Chitosan/TP micro- and nano-gels were widely investigated as systems for drug, protein, and gene
delivery [59–66]. Bovine serum albumin (BSA) was frequently used as a model payload [50,59,67].
These micro- and nano-gels proved greater protein loading capacity and provided a continuous
release of the payload up to one week [50]. Cai and Lapitsky systematically analyzed protein uptake
performance as a function of micro- and nano-gel yields [67]. The protein association efficiencies were
shown to scale almost linearly with the particle yield—which increased with the TPP and protein to
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chitosan ratios—until complete chitosan aggregation into particles. Upon increasing molecular weight
of chitosan, BSA encapsulation efficiency was enhanced and its total release at physiological pH and
ionic strength was reduced. By lowering the FA of chitosan, the encapsulation efficiency was enhanced
and the release rate was slowed down [68].
Due to the muco-adhesive properties of chitosan [69], nano-gels were widely studied as potential
nano-carries of bioactive molecules in mucous-rich tissues such as ocular and nasal ones [62,63].
Cyclosporin A (CyA) was chosen as a model compound because of its potential usefulness for the
treatment of local diseases; in vivo experiments showed that, following topical injection of CyA-loaded
chitosan nano-gels, it was possible to achieve therapeutic concentrations in external ocular tissues
during at least 48 h while maintaining negligible CyA levels in undesired zones (inner ocular structures,
blood and plasma) [62]. Chitosan/TPP nano-gels were also able to encapsulate extremely hydrophobic
drugs such as anti-hypertensives. Such systems encapsulated these drugs with high efficiency and
were able to release them in a controlled way [70]. This type of nano-gels was even suitable for the
encapsulation of anticancer agents such as doxorubicin [71].
6.2. Complex Coacervation
Complex coacervation of chitosan can be achieved through electrostatic interactions with
negatively charged polysaccharides mixed in the right proportions. The most widely used anionic
polysaccharides are hyaluronan, alginate, dextran sulfate, and carrageenan [49]. Such polyelectrolyte
complexes are commonly used as drug delivery systems in very different fields of application,
spanning from the delivery of genes to that of proteins [72].
6.2.1. Hyaluronic Acid
One of the most interesting polyelectrolyte chitosan-based complex is that formed with
hyaluronic acid (hyaluronan, HA) [73]. Chitosan-hyaluronan nano-gels are typically obtained by
dropping hyaluronan into a chitosan solution [51,74]. Conceivably, the driving forces for nano-gels
self-assembling are the gain of entropy due to the release of water molecules and counterions from
both polysaccharides together with electrostatic interactions between the two oppositely-charged
polyelectrolytes [75].
Very little is known about the influence of FA on the stability of resulting nano-gels and its
biological implications, since most authors used commercial chitosans with very similar physical-
chemical properties, typically FA < 0.2 and medium/high molecular weight. Delair and co-authors
reported limited stability of polyelectrolyte complexes based on chitosan and hyaluronan [76].
The authors claimed that the stability of such coacervates, prepared in medium with ionic strength
and pH close to physiological conditions, could be reached adding metallic ions (Zn2+).
Some of the authors of the present review evaluated the role played by FA in the stability
and biological activity of chitosan-hyaluronan nanogels [77]. Systems made with low molecular
weight chitosans were devised for the encapsulation of anti-inflammatory molecules and were able to
modulate several neutrophil functions [51]. Specifically, such nano-gels were developed as controlled
release carriers in order to provide a long-lasting supply of payload, resulting in a limited production
of neutrophil reactive oxygen species (ROS). Muco-adhesive properties of nano-gels based on chitosan
and hyaluronan can be exploited for gene delivery as well as transmucosal delivery of drugs and
proteins. CH/HA nano-gels were able to encapsulate heparin and were promising nano-carriers for
pulmonary delivery applications [78]. They were also suitable for the encapsulation of proteins such
as the growth factors VEGF and PDGF-BB [79]. Nano-gels also encapsulated plasmids with high
efficiency and were promising carriers for ocular gene therapy [75], reaching transfection levels up to
25% in cell models [80].
Hyaluronic acid is of particular interest due to its ability to interact with membrane receptor
CD44, [81] known being overexpressed in certain cancers, such as those affecting the breast [82]
and liver [83], thereby cueing antineoplastic drugs for a selective targeting. Deng and co-authors
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developed chitosan-hyaluronan nano-gels suitable to overcome drug resistance in breast cancer [84].
An antineoplastic drug, doxorubicin, and miR-34a, a potent endogenous tumor suppressive molecule,
were co-encapsulated in nano-gels. In vitro and in vivo experiments showed that nano-gels enhanced
anti-tumor effects of doxorubicin and miR-34a, thus resulting a promising therapeutic strategy
for enhancing anti-tumor therapy. Lallana et al. studied the role of RNA avidity for chitosan on
the transfection efficiency by using a small library of chitosans (variable molecular weight and
FA) in CD44-expressing cells [85]. Chitosan with high FA showed limited stability, were poorly
internalized and, therefore, were not effective in RNA delivery. The best transfecting particles
were those with lower FA. Tirelli and co-workers deeply investigated the possibility to use a
hyaluronan coating on chitosan-TPP nano-gels [81,86–89]. They reported that hyaluronic acid coating
reduced the immunogenity and toxicity of nano-gels [87–89]. Almalik et al. provided evidence that
CD44-mediated endocytosis was responsible for the uptake of materials where HA was used as
the coating agent [81,90]. The same author evaluated the influence of chitosan molecular weight
on physical-chemical properties of the nano-gels and DNA loading [86]. Molecular weight did
not influence DNA loading capacity; conversely, it influenced the physical-chemical properties of
nano-gels. Specifically, higher molecular weight chitosan increased porosity (i.e., decreased the
crosslink density), also causing larger dimensional changes upon varying the osmotic pressure or after
drying. HA penetrated deeply into the more porous nano-gels composed of high molecular weight
chitosan, whereas formed a corona in lower molecular weight chitosan nano-gels [86].
6.2.2. Alginate
Alginate is another widely used polysaccharide to form chitosan-based nano-gels [49]. Stokke and
co-workers investigated the possibility to synthetize coacervates using polymers with different
physical/chemical composition and by varying the modality of mixing of the two polysaccharides [91].
The mixing order influenced the size of nano-gels, whereas the net charge ratio between chitosan
and alginate and the molecular weight of both polymers affected both the particle size and surface
charge. Abreu and collaborators investigated the influence of alginate content, chitosan molecular
weight and micro-gel preparation method on the reaction yield, particle size, and swelling degree [92].
The main parameter affecting the reaction yield resulted the chitosan molecular weight. By tuning the
alginate content it was possible to vary the charge density and the swelling degree of the micro-gels.
The same authors provided an equation aimed at correlating different parameters. Hence, it was
possible to predict the desired features for a controlled drug release of payloads by properly tuning
some properties of the initial system.
6.2.3. Dextran Sulfate
Costalat et al. developed reversible nano-gels based on chitosan and dextran sulfate [93].
Nano-gels formed and dissolved simply by tuning the ionic strength of the system via dialysis.
In the presence of an excess of polycation, colloidal gels were exclusively obtained. At low salt
concentrations, the spontaneous gelation provided macro-gels with different homogeneity [94].
Weber and collaborators investigated the possibility to use nano-gels based on chitosan and dextran
sulfate as potential delivery systems for an antigenic protein (p. 24, the capsid protein of HIV-1),
useful as vaccine carriers [95]. They tuned experimental conditions, molecular mass and FA in order to
retain the colloidal properties of the carrier in physiological conditions. After subcutaneous injection
in mice, a specific immune response was observed and both the cellular and the humoral responses
were stimulated.
6.2.4. Carrageenan
Rodrigues et al. studied the possibility to form nano-gels based on chitosan and carrageenan [96].
The further addition of TPP reduced the dimensions and improved the stability of the nano-gels.
The authors microencapsulated BSA by spray-drying and resulting formulations showed good
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biocompatibility toward different cell lines. Such nano-gels were shown to be promising as protein
carriers for pulmonary and nasal transmucosal delivery [97].
7. Thermosensitive Gels
Thermo-sensitive gelling systems consist of stable, low viscosity, aqueous solutions that turn
into a gel state upon heating. The sol-gel transition usually occurs at neutral pH and takes a few
minutes [98,99]. The first evidence of the possibility to synthesize thermosensitive gels based on
chitosan was reported in 2000 by Chenite and collaborators [100]. Thermo-sensitive gelling systems
were devised by combining chitosan and polyol-phosphates, polyol-bearing molecules, or inorganic
phosphate molecules. At first, β-glycerophosphate (β-GP) was used as gelling agent, [100] then
the attention moved also toward other polyol-phosphates such as glucose-1-phosphate (G1-P) and
glucose-6-phosphate (G6-P) [101]. As polyol molecules, 1,3-propanediol, 1,2-propanediol, mannitol,
trehalose, and mannitol were used as well. As inorganic gelling agents, hydrogen phosphate
salts—ammonium, sodium or potassium—were also used [99].
The gelling mechanism of chitosan in the presence of β-GP was elucidated by Lavertu and
co-workers. They proposed that precipitation and gelation of chitosan derived from heat-induced
transfer of protons from chitosan to β-GP [102]. This phenomenon would induce charge neutralization
in chitosan, facilitating hydrophobic interactions between polymer chains and allowing attractive
inter-chain forces to form a physical gel (Figure 6). By using β-GP as a crosslinker, the gelation
temperature, depending on the amount of β-GP, ranged from 15 to 85 ◦C. The resulting fraction
of protonated glucosamine monomer was temperature independent but increased with decreasing
chitosan FA and with increasing salt content. Supper et al. further investigated the mechanism of
the gelation process, comparing different systems based on chitosan and various polyol-phosphates,
such as β-glycerophosphate, glucose-1-phosphate and glucose-6-phosphate, varying in the chemical
structure of the polyol parts [101]. Macroscopic gelling behavior of the solutions, such as transition
temperature, gelation time, and gel strength, indicated that increasing the size of the polyol part
prevented the interactions between the chitosan chains, strongly influencing the gelling process.
Injectable thermo-sensitive gels have shown great potential in biomedical applications,
including local drug delivery and tissue engineering [103,104]. Nevertheless, some authors reported
problems about storage stability, both at room temperature, as well as at refrigerated conditions [98,105].
Neither lyophilization was able to retain the viscoelastic properties of the chitosan-based thermogelling
solutions [106]. To improve the stability, additional polyol-phosphates, such as glucose-1-phosphate
(G1-P) and glucose-6-phosphate (G6-P) have been investigated [101]. By using G1-P it was possible to
improve the stability of formulations. Resulting systems were found stable for at least nine months
at 2–8 ◦C, at variance with what was observed in the case of β-GP (one month) [98]. Furthermore,
the solution was easy to inject and showed a sustained release for days to weeks for hydrophilic model
compounds, thus demonstrating that the chitosan/G1-P system could be suitable for the prolonged
delivery of drugs. Supper and co-workers also evaluated the influence of the molecular weight and
concentration of polymer, as well as that of G1-P on thermogelling potential [98]. The decrement of
chitosan molecular weight and its concentration resulted in a significant decrease of the gelation time,
in agreement with previous reports based on β-GP [107]. The same effect was achieved by increasing
the G1-P concentration, in agreement with previous reports on chitosan β-GP systems [98,108,109].
The sol/gel transition took place at around body temperature and was not fully thermo-reversible,
confirming the potential of chitosan/G1-P solutions as an injectable ready-to-use forming gel in situ [98].
An alternative approach for improving the storage stability deals with the addiction of stabilizing
agents. When trehalose or mannitol were used, the re-hydrated sample displayed thermosetting
properties, thereby retaining injectable properties [106].
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Giving the peculiar properties of this set of materials, Chenite and co-workers undertook biological
tests: specifically, they injected such formulations, which gelled upon implantation in vivo; all implants
were intimately integrated within the subdermal fibrous membranes. Formulations were used also as
an encapsulating matrix of chondrocytes for tissue engineering applications [100].
These thermogelling solutions were widely studied for the development of parenteral drug
delivery systems, which enabled a sustained release of potentially encapsulated active substances [101].
In order to achieve a prolonged release of low molecular weight payloads, drug-loaded carrier particles
were also incorporated in the thermogels [99]. In case of a further strengthening of the network was
needed, an additional polymer and/or additives were used. Such biodegradable drug delivery systems
were suitable as in situ forming depots (ISFD) after subcutaneous administration and were exploited
in different applications. Nevertheless, some authors reported that an inflammatory reaction occurred
in the tissue surrounding the gel [98,110].
Thermosensitive gels based on chitosan and β-GP were studied as materials for cartilage and bone
regeneration. Hoemann and co-workers described the utility of such materials as arthroscopically-
injectable vehicles for cell-assisted cartilage repair [111]. They developed a cytocompatible chitosan
solution that was space-filling, gelled within minutes, and adhered to cartilage and bone. The in
situ-gelling chitosan solution was able to support in vitro and in vivo accumulation of cartilage
matrix by primary chondrocytes, while persisting in osteochondral defects at least one week. Huang
and co-workers developed a biphasic scaffold platform able to retain cells homogeneously [112].
This biphasic scaffold platform was functionalized with an affinity peptide targeting bone marrow stem
cells (BMSC), to provide BMSC-specific homing both in vitro and in vivo. The functional biomaterial
stimulated stem cell proliferation and chondrogenic differentiation in vitro. After in vivo implantation,
compared with routine surgery or control scaffolds, the functional biomaterials induced higher cartilage
repair without complications. This functional biphasic scaffold could provide a biomaterial framework
for one-step tissue engineering strategy by homing endogenous cells to stimulate tissue regeneration.
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BMSC were also successfully encapsulated in gels supplemented with collagen [113]. The presence of
chitosan increased the alkaline phosphatase activity and calcium deposition in osteogenic medium.
These composite materials demonstrated potential as matrices for cell encapsulation and payload
delivery, or as in situ gel-forming materials for bone repair.
Some authors reported issues about the inadequate mechanical strength of thermoresponsive gels
based on chitosan for osteochondral repair [99,114]. To address such flaws, Huang and co-workers
constructed a solid-supported thermogel comprising of a chitosan gel system and demineralized bone
matrix [114]. Compared with either the simple gel or the demineralized matrix, the hybrid biomaterial
showed superior porosity, equilibrium swelling and degradation rate. The hybrid scaffolds exhibited
an increased mechanical strength. BMSCs maintained viability above 90% and the cell retention
of the hybrid scaffolds was more efficient and uniform than other materials. Matrix production
and chondrogenic differentiation of BMSC in the hybrid scaffolds were superior to its precursors.
These experimental evidences indicated that that solid-supported thermogel could be an attractive
biomaterial framework for cartilage tissue engineering [114]. An alternative approach to improve
mechanical properties was aimed at including nano-crystals of β-tricalcium phosphate, the latter able
to interact via physical interactions. The systems exhibited a gel-phase transition at body temperature,
and a three-dimensional network with typical rheological properties of a strong gel. The presence
of the inorganic phase provided a structure with physical/chemical composition akin to that of
natural bone tissue. Overall, such formulations seemed suitable for hard tissue regeneration [115].
A composite scaffold was obtained by combining chitosan and demineralized bone matrices modified
with the E7 affinity peptide, able to bind BMSC, for potential application in cartilage regeneration [116].
The composite scaffold presented an appropriate porosity suitable for supporting cell adhesion and
proliferation, increased matrix production and improved chondrogenic differentiation ability in vitro.
After implantation in vivo, much more cartilage-like structures than the control group were found.
Such composite scaffold could be a promising option for repairing irregularly shaped cartilage defects.
The addiction of zinc (Zn) to thermosensitive gels allowed for enhancing antibacterial activity and
promoted osteoblast differentiation, therefore having a potential as injectable in situ forming matrix
for bone tissue engineering applications [117]. The antibacterial activity of the resulting formulations
was successfully improved also by using nanocomposites materials based on silver and palladium.
This set of materials proved osteogenic ability, displayed antibacterial activity and lack of toxicity.
Hence, they are promising for dental surgery purposes [118].
Different approaches for obtaining thermosensitive gels based on chitosan were undertaken
using inorganic phosphate hydrogen phosphate salts. Nair and co-workers reported that by adding
different concentrations of ammonium hydrogen phosphate to chitosan solution it was possible to
tune the gelling time from 5 min to 30 h at 37 ◦C [119]. These gels did not show any toxicity toward
osteoblast-like cells. Moreover, they were suitable as stem cell and payload carrier. Ta and co-workers
developed thermosensitive gels based on chitosan and inorganic orthophosphate [104]. These authors
reported that monobasic and tribasic phosphate salts were not effective in inducing gelation of chitosan;
conversely, dibasic phosphate salt such as dipotassium hydrogen orthophosphate was able to form
gels. Gelation temperature and gelation time were tuned by varying chitosan and salt concentrations
in the final formulation. Resulting systems were effective to release the entrapped macromolecules
and were found to be cytocompatible. Li and co-workers detected two sol-gel transition temperatures
using similar formulations, namely 4 and 37 ◦C. Strikingly, the formulation reverted to a solution
around 30 ◦C [120]. By increasing the temperature up to 43 ◦C, a similar gel-sol transition, as well as a
decrease in turbidity, was detected.
8. Interpenetrating Polymer Network (IPN)
Among physical gels, an interesting category is represented by the interpenetrating polymer
networks (IPNs). According to the definition given by the IUPAC Gold Book, IPNs are networks
comprising two or more polymers that are at least partially interlaced on a molecular scale, but not
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covalently bonded to each other and cannot be separated unless chemical bonds are broken.
Unlike blends of heterogeneous polymers, IPNs show a network of chains held together by physical
entanglements or weak interactions and, thus, are intimately mixed and mechanically interlocked [121].
In light of this feature, the main advantage of IPNs is to combine the best properties of single-network
gels and the properties of a system in which the cooperation between chains makes it possible to
achieve superior mechanical and biological features, as the sum of the contribution from both polymers.
Hence, an IPN is an advanced multicomponent polymeric system in which it is possible to tune the
properties by choosing the polymer combinations [122]. Both synthetic and natural macromolecules are
used to such a purpose. Synthetic polymers are chosen to create medical devices because, in general,
they show elevated mechanical strength, are cheap, easy to prepare, and can be chemically modified.
In contrast, natural biopolymer gels are highly biocompatible, easily biodegradable, and can induce
specific cellular responses. In spite of this, they often show lower mechanical strength [123]. In this
context, IPNs can be made by both synthetic and natural polymers: the former would provide the
right stiffness and support, while the latter would enhance cellular adhesion and stimulate growth and
metabolism [124]. IPNs, as reported in [125], can be classified according to two basic criteria (Figure 7).
The first classification is of morphological nature, as it is based on the final structure of the polymers
that form the network; it divides them into full-interpenetrating networks (FIPNs), often defined just
IPNs to simplify, and semi-interpenetrating networks (SIPNs).
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containing the second polymer (B) or its precursors and, through the swelling of the first network,
the polymer/monomers B is embedded into the network A (impregnation step); when polymer B
is crosslinked in a second moment, it becomes a FIPN. Instead, if polymer B is left uncrosslinked,
the system remains a SIPN. This method provides the advantage of being easily modified and adapted
to different gel systems, but it requires large amounts of the second polymer to reach an efficient
swelling. It takes a long time (about 1–2 days) to complete the process and it is tailored for crosslinked
polymers that hardly behave as self-healing gels. In contrast, more recently the in situ approach has
gained much attention. It consists in mixing together, in the same reaction medium, both polymers
and crosslinkers; in the case of FIPN, the formation of the two networks can occur simultaneously
or manifest in two different moments. Nevertheless, there is a higher probability of cross-reactions
between various components, thus it is important to choose the right crosslinking molecules. The main
advantages of using the in situ approach are the speed of the process, which can reach completion
in 1–2 h, the reduced number of passages that makes the whole procedure easier, and its high
reproducibility [129].
The overall tendency is to design medical devices based on IPNs that can mimic the ECM,
thus allowing and enhancing the adhesion and growth of cells on the substrate. Chitosan represents
an ideal polymer for such a purpose. Chitosans can behave as “smart” stimuli-responsive polymers
when are part of gel systems, they can respond to external factors such as temperature, electric current,
solvent composition, pH, and ionic concentration. Chitosan-based IPNs can be prepared for different
applications in the biomedical field, such as drug delivery, tissue engineering, and scaffolding [22].
8.1. Drug Delivery and Wound Dressing
Hernández et al. proposed a full-IPN as micro-gel for drug delivery based on poly-N-
isopropylacrylamide (PNIPAM) coupled with chitosan and synthesized according to the in situ
technique [130]. Such system showed thermo- and pH-responsive behavior, thereby allowing for
a controlled drug delivery. NIPAM and chitosan were mixed together in acetic acid, then NIPAM
and N-N′-methylenbisacrylamide (BIS) were added. Finally, tetramethylethylenediamine (TEMED)
and ammonium persulfate (APS) were mixed and let the reaction occurring. Finally, gels were
dialyzed and freeze-dried. The gel showed a high percentage of swelling at low pH because of the
presence of chitosan, while the response to temperature was principally due to PNIPAM, which had
a lower critical solution temperature (LCST) of 32 ◦C. Under these experimental conditions amide
groups in hydrophilic segments of the polymer and water molecules showed strong interactions
because of hydrogen bonds. These characteristics made the gel as an ideal system for the setting
up of controlled drug delivery devices. Another example of how to exploit the pH sensitivity of
this kind of systems comes from [123]. In this work it is described a SIPN formed between a
derivative of chitosan (N-Succinyl chitosan, NSC) crosslinked with glutaraldehyde and non-crosslinked
poly-acrylamide-co-acrylic acid (poly(AAm-co-AA)) embedded into the chitosan network. The gel was
synthesized by the in situ approach and showed a porous structure thanks to the high hydrophilicity
of NSC, while the embedded Poly(AAm-co-AA) created more homogeneous pores. The system greatly
swelled at pH 7.4 because of the presence of the carboxylic groups that deprotonated into carboxylate
ions, thus causing repulsion of the chains. It has been tested for the controlled release of 5-fluorouracil,
an anti-tumor and anti-metabolite drug in order to increase the leakage of the drug in the colon rather
than in the stomach after oral administration. Furthermore, the semi-IPN could be also considered for
tissue engineering purposes thanks to the excellent interconnected porous network, which favors an
efficient exchange of nutrient and gas. The idea of controlling the gel swelling by multi-stimuli response
systems has been deeply described in [131]. In this paper it is reported that a semi-IPN composed by
chitosan was embed in a crosslinked network of polyacrylamide (PAAm) with an in situ synthesis.
The resulting gel showed a different swelling upon changing of pH, temperature, ionic strength,
and electric field applied, allowing to control in multiple and, thus, more sophisticated ways the release
of payloads entrapped in its mesh. The system was proposed for drug delivery and wound dressing.
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Another example of in situ synthesis has been proposed by Treenate et al. [128] with a semi-IPN
formed by a network of alginate ionically crosslinked with CaCl2 and a polymer of hydroxyethylacryl
chitosan (HC) in which the crosslinker was added after mixing of alginate and HC: in this way HC was
homogeneously dispersed into the matrix of alginate. The system was stable at pH 1.2, and degraded
at pH 7.4, making the network useful for a controlled drug release. The tensile strength and elongation
of the gel films were 12.1 MPa and 162%, respectively, granting the system with the mechanical
properties adequate for the development of wound dressings. A different way to interlace polymers
is represented by UV treatment in the presence of a photoinitiator. As reported in [132], a SIPN was
formed by a single reaction mixing a derivative of chitosan, the water-soluble N-carboxylethyl chitosan
(CECS), and 2-hydroxyethyl methacrylate (HEMA). Both polymers were solubilized in water with
a photoinitiator, then poured into a mold and finally irradiated by a UV light source. The system is
suitable for transdermal drug delivery and wound dressing. Similar chitosan derivatives and partner
polymers were used in applications somehow resembling the ones described above.
8.2. Tridimensional Cellular Scaffolds
An interesting application of IPNs is the design of 3D scaffolds for the growth of various
cells, since they can mimic the cellular environment and improve cell viability and proliferation.
Some authors worked on a SIPN composed of a chitosan-derivative (CML, with methacrylic and lactic
acids sequentially grafted onto chitosan backbone) crosslinked in situ by UV light in the presence of an
initiator to form the first network and then loaded with gelatin [133]. The gelatin addition reduced
pores and the swelling ratio of gels, thus enhancing their strength. Physical-chemical features of the
scaffold ensured the maintaining of morphology and phenotype of chondrocyte cells because the
scaffold mimicked well the ECM. A very intriguing study is reported in [124] which is focused on the
study of different type of cellular scaffolds made by chitosan and N,N-dimethylacrylamide (DMAAm)
crosslinked with gamma-irradiation. In situ synthesis was performed for both SIPNs (only DMAAm
crosslinked) and FIPNs. SIPNs showed a higher percentage of swelling compared to FIPN due to the
higher crosslinking of DMAAm, while the degradation is higher in the case of FIPN as temperature
increased. Moreover, the pore size was smaller and less dispersed in SIPN than in FIPN.
8.3. Bio-Electro Sensing and Soft Actuators
The capability of chitosan to respond to electric current variations has led to the development
of biosensors and energy transducers that can find large applications in the field of electro-sensing
and robotics. Kim et al. [134] reported that an IPN made of poly (vinyl alcohol)—PVA—and chitosan
crosslinked by UV radiation by means of an in situ reaction could bend differently depending on the
applied electric stimulus. The network showed a different swelling depending on salt concentration
and temperature, due to the association and dissociation of hydrogen bonds between hydroxyl groups
in PVA and the amino groups in chitosan. The high mechanical strength conferred by PVA and the
good biocompatibility of chitosan made the system useful as a component for artificial organ, such as
muscle-like contractile structures, sensors, switches, and electric current modulated drug-delivery
systems. Few years later, the same authors developed another electric-responsive gel, i.e., a SIPN
composed of chitosan and chemically crosslinked poly-hydroxyethyl methacrylate (PHEMA) [135].
This new kind of network was sensitive to electric current and showed various bending degrees
depending on electric stimulus. Its electroresponsive behavior was also affected by electrolyte
concentration of the external solution. The contribution of chitosan IPNs for the development of
biosensor devices with regard not only to the direct response to various kind of stimuli, but also
the entrapping of enzymes used to detect molecules of interest, as networks based on chitosan can
mimic well the environment in which enzymes naturally operate. Zeng et al. describes a biosensor
made of a carbon electrode covered with a film of semi-IPN composed of polyacrylamide (PAM) and
chitosan [136]. The gel film could entrap hemoglobin in its native state and allowed the redox reaction
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for which the biosensor was built. This system represents an ideal model to study electron transfer by
heme enzymes.
8.4. Tissue Engineering
Huang et al. developed a semi-IPN based on two types of crosslinking, both covalent and
ionic [137]. The first network was obtained with covalent crosslinking of acrylamide and maleic
acid and the simultaneous entanglement of a water-soluble carboxymethyl chitosan (CMC) in the
mesh exploiting an in situ approach. Thereafter, following a sequential synthesis, the network was
immersed into a solution of ferric ions, which further strengthened the gel and accommodated the
strain by rapid reversible dissociation and association. The system showed a tensile stress of about
1.44 MPa and an antibacterial activity, thus suggesting it for many biomedical applications from wound
dressing to gene/drug delivery and tissue engineering. The strategy of using molecules that naturally
reside in the ECM to mimic an ideal situation for cell growing is often exploited in tissue engineering
and the SIPN reported in [138] is a good example. The authors proposed an in situ synthesis for a
semi-IPN composed of a network of crosslinked glycol-chitosan and type I and III collagen. The gel
showed a nano-fibrillar porous structure and it was mechanically stable under continuous dynamic
stimulation. These characteristics made the gel a good scaffold for cell viability, metabolism, adhesion,
and migration, and could be proposed for uses in tissue engineering, as for the replacing of vocal folds
or heart valves, which represent mechanically challenging tissues. An example of water absorbent
material was reported by Wang et al. [126]. The gel studied was composed of a first network of gelatin
crosslinked with chitosan; in a second moment, poly (vinylpyrrolidone), PVP, and its crosslinker
were added to the first network following the sequential method. The innovation was represented
by the use of microwave and ultrasonic techniques to obtain the crosslinking, allowing a very quick
synthesis. The tensile strength was very high (approximately 90 MPa), making the system suitable for
tissue engineering and biomedical applications, which would involve the need of high mechanical
performance. Finally, an example of FIPN made by in situ synthesis and formed by poly (vinyl alcohol),
chitosan, and poly (acrylic acid) is reported by Zhang et al. [139]. The network showed a high swell
ratio, thus considering it as a potential modulator system in the biomedical field.
9. Chitosan Derivatives
Chitosan displays several interesting features, which have been discussed in the previous sections.
However, poor solubility at neutral pH, especially for medium/high molecular weight chitosans
with FA < 0.4 and lack of specific biological signals are severe limitations to its large-scale use in the
biotechnological field where direct contact with cells and/or tissues is foreseen. The derivatization
of chitosan can overcome some of aforementioned flaws. The modification can be specific, involving
the amino group (–NH2) at C2 position, or nonspecific, involving hydroxyl groups (–OH) at C3
and C6 positions [140]. The hydroxyl groups of chitosan have nearly equal reactivity. One of
the most widely used methods to derivatize chitosan is the quaternization of the amino group
to improve the antibacterial properties [141]. Another quite simple reaction refers to reductive
amination. The reaction can be performed in aqueous solutions under mild conditions yielding
randomly-distributed substituents along the chitosan chain [140].
In a paper by Diolosà et al. chitosan was modified with methacrylic acid (Chit-MA70) on 16%
of the amino groups aiming at investigating its effect on the durability of adhesive interfaces to
improve the clinical performance of dental restorations [142]. Chit-MA70 was blended into a primer
of an “etch-and-rinse” experimental adhesive system and tested on human teeth. The presence of
methacrylate moieties and of residual positive charges on the polysaccharide chain allowed Chit-MA70
to covalently bind to the restorative material and electrostatically interact with demineralized dentin.
The Chit-MA70 containing an adhesive system showed values of the immediate bond strength
(26.0 ± 8.7 MPa) comparable with the control adhesive system (25.5 ± 8.7 MPa). However, it was
shown that upon performing thermo-mechanical cycling treatment of the dental restoration on human
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teeth, the adhesive with the methacrylate-modified chitosan, in variance with the control adhesive,
did not show any decrease in the bond strength (28.4 ± 8.8 MPa). The modified chitosan was proposed
by the Authors as a component of the “etch-and-rinse” adhesive system to efficiently improve the
durability of dental restorations.
An interesting approach for the modification of chitosan backbone is based on the introduction of
sugars as flanking groups. As an example, mannosylated chitosan was used for the specific recognition
to antigen presenting cells such as B-cells, dendritic cells, and macrophages [143]. Other sugar
derivatives of chitosan have been reported to show antioxidant activities [144] and enhanced release
of nitric oxide, TNF-α, and IL-1 β in macrophages [145].
Physical Gels Based on Chitosan Derivatives
The use of chemically-modified chitosans was widely exploited to enhance pH sensitivity or
biodegradability of thermo-sensitive gels based on chitosan [99]. Interesting mechanical properties
were detected by You and co-workers by using a gel based on a quaternized chitosan and poly
(acrylic acid) [146]. The mechanical behavior of such gels was tuned from stiff and viscoelastic to
soft and elastic by changing the poly (acrylic acid) content. Moreover, resulting gels displayed
excellent shape-memory behavior due to the reversible properties of the ionic bonds and were
endowed with self-recovery features. This peculiar behavior was attributed to the high charge
density and solubility of quaternized chitosan, which enabled the formation of strong electrostatic
interactions in the gels. Another interesting approach dealt with the modification of chitosan
with two water-soluble thermosensitive polymers, namely poly (N-isopropylacrylamide), PNIPAm,
and poly (N-vinylcaprolactam), PVCL [147]. Fang and co-workers grafted chitosan with poly
(N-isopropylacrylamide) to obtain temperature-sensitive gels able to release in a controlled way
both hydrophilic and lipophilic drugs in an in vitro drug release experiment [148]. In vitro cell culture
experiments with chondrocytes and meniscus cells in the gels combined with hyaluronic acid showed
beneficial effects on the cell phenotypic morphology, proliferation, and differentiation [149].
An alternative approach for fabricating thermosensitive gels based on chitosan derivatives was
proposed by Tang and co-workers [150]. Carboxymethyl chitosan was combined with oxidized
gellan gum, thus obtaining a gel with an almost physiological gelation temperature and able to
significantly enhance the viability of encapsulated chondrocytes. The obtained formulation resulted
to be a promising material for cartilage tissue engineering. Chitosan grafted with glycolic acid and
phloretic acid were designed to obtain biodegradable injectable chitosan gels through enzymatic
crosslinking with horseradish peroxidase (HRP) and H2O2 [151]. Short gelation times in the range of
tens of seconds were detected culturing chondrocytes, revealing that cells were viable and retained
their round shape. Such gels are promising as an artificial extracellular matrix for cartilage tissue
engineering. An interesting use of chitosan and hyaluronic acid derivatives was proposed by Manna
and co-workers [152]. Chitosan was grafted with adenine, whereas hyaluronic acid was modified
with thymine and the self-assembly was obtained by means of hydrogen bonding between DNA base
pairs substituted on the backbone of polymers. Alternated layers of each single polymer type were
deposited on the surface, by obtaining a multilayer film, which did not show cytotoxicity.
10. Lactose-Modified Chitosan (CTL)
Lactose derivatives of chitosan, indicated as CTL as a short name (previously reported in the
literature as Chitlac), have recently emerged as intriguing examples of engineered biopolymers for
potential applications in the field of drug delivery and tissue engineering [153]. From the chemical
point of view, CTL is obtained through a N-alkylation reaction, which involves the amino groups of
chitosan (Scheme 1).
Gels 2018, 4, 67 20 of 29
Gels 2018, 4, x FOR PEER REVIEW  19 of 28 
 
were detected by You and co-workers by using a gel based on a quaternized chitosan and poly 
(acrylic acid) [146]. The mechanical behavior of such gels was tuned from stiff and viscoelastic to soft 
and elastic by changing the poly (acrylic acid) content. Moreover, resulting gels displayed excellent 
shape-memory behavior due to the reversible properties of the ionic bonds and were endowed with 
self-recovery features. This peculiar behavior was attributed to the high charge density and solubility 
of quaternized chitosan, which enabled the formation of strong electrostatic interactions in the gels. 
Another interesting approach dealt with the modification of chitosan with two water-soluble 
thermosensitive polymers, namely poly (N-isopropylacrylamide), PNIPAm, and poly (N-
vinylcaprolactam), PVCL [147]. Fang and co-workers grafted chitosan with poly (N-
isopropylacrylamide) to obtain temperature-sensitive gels able to release in a controlled way both 
hydrophilic and lipophilic drugs in an in vitro drug release experiment [148]. In vitro cell culture 
experiments with chondrocytes and meniscus cells in the gels combined with hyaluronic acid showed 
beneficial effects on the cell phenotypic morphology, proliferation, and differentiation [149]. 
An alternative approach for fabricating thermosensitive gels based on chitosan derivatives was 
proposed by Tang and co-workers [150]. Carboxymethyl chitosan was combined with oxidized gellan 
gum, thus obtaining a gel with an almost physiological gelation temperature and able to significantly 
enhance the viability of encapsulated chondrocytes. The obtained formulation resulted to be a 
promising material for cartilage tissue engineering. Chitosan grafted with glycolic acid and phloretic 
acid were designed to obtain biodegradable injectable chitosan gels through enzymatic crosslinking 
with horseradish peroxidase (HRP) and H2O2 [151]. Short gelation times in the range of tens of 
seconds were detected culturing chondrocytes, revealing that cells were viable and retained their 
round shape. Such gels are promising as an artificial extracellular matrix for cartilage tissue 
engineering. An interesting use of chitosan and hyaluronic acid derivatives was proposed by Manna 
and co-workers [152]. Chitosan was grafted with adenine, whereas hyaluronic acid was modified 
with thymine and the self-assembly was obtained by means of hydrogen bonding between DNA base 
pairs substituted on the backbone of polymers. Alternated layers of each single polymer type were 
deposited on the surface, by obtaining a multilayer film, which did not show cytotoxicity. 
10. Lactose-Modified Chitosan (CTL) 
Lactose derivatives of chitosan, indicated as CTL as a short name (previously reported in the 
literature as Chitlac), have recently emerged as intriguing examples of engineered biopolymers for 
potential applications in the field of drug delivery and tissue engineering [153]. From the chemical 
point of view, CTL is obtained through a N-alkylation reaction, which involves the amino groups of 
chitosan (Scheme 1). 
 
Scheme 1. Synthesis of chitlac (CTL) through N-alkylation of chitosan in the presence of lactose. 
The introduction of lactitol side chains on the chitosan backbone markedly modifies the 
physical-chemical properties of the polysaccharide rendering it soluble at neutral pH values and 
surprisingly miscible with polyanions, such as hyaluronan and alginate [154]. In the latter case, the 
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The introduction of lactitol side chains on the chitosan backbone markedly modifies the
physical-chemical properties of the polysaccharide rendering it soluble at neutral pH values and
surprisingly miscible with polyanions, such as hyaluronan and alginate [154]. In the latter case,
the interactions between the positive charges on CTL and the negative ones on alginate leads to the
formation, under controlled conditions, of soluble complexes which determine a synergistic behavior
both in dilute and semi-dilute conditions [155,156]. CTL was also used for the preparation of ternary
mixtures with both alginate and hyaluronan [157,158]. A study of the conformational properties of CTL
has been performed by means of NOE-NMR and molecular dynamics which showed a high flexibility
of the lactitol side chain when compared to the chitosan backbone [159]. In addition, the lactitol side
chain seems to adopt two distinct conformational orientations with respect to the polysaccharide
backbone: a folded conformation and an extended one. In both conformations the side chains are well
immersed in the aqueous solvent, showing a good degree of solvation. Molecular dynamics performed
on decamers showed a propensity to form an extended 32 helical geometry, but the preference shifted
to the 21 geometry with limited electrostatic interactions [160].
Leaving aside the physical-chemical properties, Chitlac has raised interest for its biological activity
towards different primary cultures and cell lines. In particular, Chitlac promoted the aggregation
of articular chondrocytes through the involvement of Galectin-1, [161,162] stimulating the production
of collagen and glycosaminoglycans within an otherwise inert 3D architecture [163]. Similar biological
activity has also been noticed on an osteoblast-like cell line [164]. Recently, cell aggregation promoted
by lactose derivatives of chitosan was a prerequisite for the commitment of adipose-derived stem
cells to the chondrogenic lineage [165]. Along this line, a lactose-modified chitosan was used to
develop a hyaluronic acid-based hydrogel inducing stem cell aggregation during differentiation [165].
In addition, Chitlac was able to promote neuronal growth, differentiation, maturation, and formation
of synapses, thus representing a good candidate for the development of complex bio-constructs for
central nervous system regeneration [166].
Recently, a peculiar response of Chitlac-based macro-gels was noticed in the presence of a transient
crosslinker, such as boric acid. In particular, shear-thickening and strain hardening effects of the
chitlac-boric acid system grant it a mechanical response which is very similar to the one found
for natural components of the extracellular matrix, such as collagen and neurofilaments [167,168].
This might disclose a new role for Chitlac in the field of biomaterials design and its involvement in
mechanotransduction [169].
Moreover, Chitlac was found to form nano-gels in the presence of TPP as a crosslinker [153].
Resulting colloids were found to be highly monodisperse but, at the same time, poorly stable in
physiological conditions of ionic strength, pH and temperature. Some of aforementioned limitations
have been recently solved by reducing the amount of TPP, correspondingly replacing with low
molecular weight hyaluronan [170]. The use of the anionic polysaccharide allowed for the synthesis of
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spherical-like coacervates, which proved to be stable against dissolution, behaving as pH-responsive
carriers, thus, suitable for potential candidates in drug delivery.
11. Outlook
In this review we have summarized the main gelling concepts for synthesizing physical chitosan
gels with different sizes and geometries. Key polymer features, such as the frequency of two
building sugars—i.e., glucosamine and N-acetyl-glucosamine—and molecular weight are pivotal
for the setting up of ordered networks. In addition, polymer concentration and external variables,
such as temperature, pH, ionic strength, and crosslinker to chitosan monomer ratio, are in the same
way fundamental for achieving a homogeneous gelation. It is possible nowadays to switch from a
stable ensemble of sphere-like micro/nano-colloids to macrostructures by varying the aforementioned
parameters. Resulting chitosan-based systems find a wide range of applications in the biomedical
sector, spanning from the encapsulation and ensuing delivery of molecule therapeutics to their use as
suitable scaffolds for cellular colonization.
In view of properly optimizing and customizing chitosan gels, chemical modifications of the
parent biopolymer are often required. A lactose-modified chitosan named Chitlac is currently under
investigation in our research group, since it showed intriguing biological features. Recent research
records have highlighted the feasibility of forming Chitlac-based networks characterized by intriguing
physical properties. One of the striking findings addressed the need to create a mechano-responsive
material akin to what known for proteins composing the extracellular matrix (ECM). These results
pave the way for a potential usage of Chitlac as a biomimetic ECM-substitute.
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